Daniel Tuden, PhD

Director, Reimbursement Policy and Government Affairs

“I like the opportunity to help innovative life science technologies. I can do this at Quorum because we have the full armamentarium of reimbursement services, so I can implement any activity that will position an innovative technology to make an impact in patient care.”

Dr. Tuden is an experienced expert on market access and reimbursement issues for new medical technologies. In the past he has been Senior Vice President at the Neocure Group, a market access and reimbursement consultancy; Associate Director of Marketing at Genentech; Director of Marketing and Director of Reimbursement and Health Economics at Boston Scientific; and a Senior Associate at Covance. He has worked on technologies in the area of cardiology, neurology, oncology, ophthalmology, peripheral vascular disease, molecular diagnostics, cardiac arrhythmias and stroke.

Education

PhD in Public Policy, Goldman School of Public Policy, University of California Berkeley

Master of Public Policy Goldman School of Public Policy, University of California Berkeley

MSc, Economic History, London School of Economics

BA, Government, Cornell University

Request a Consultation